KT-333

News alerts, weekly reports and conference planners

Company:

Kymera Therap

Drug class:

STAT3 protein degrader

Related drugs:

‹

›

No biomarker	Peripheral T-cell Lymphoma	No biomarker	Peripheral T-cell Lymphoma	KT-333 Sensitive: B - Late Trials KT-333 Sensitive : B	KT-333 Sensitive: B - Late Trials KT-333 Sensitive : B
No biomarker	Cutaneous T-cell Lymphoma	No biomarker	Cutaneous T-cell Lymphoma	KT-333 Sensitive: B - Late Trials KT-333 Sensitive : B	KT-333 Sensitive: B - Late Trials KT-333 Sensitive : B

Associations
(2)